Optimizing magnetic nanoparticle based thermal therapies within the physical limits of heating

Annals of Biomedical Engineering

Volumn 41, Issue 1, 2013, Pages 78-88

  Etheridge, M L ^a   Bischof, J C ^a,b  

^a University of Minnesota   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Clinical application; Heat transfer; Magnetic fluid hyperthermia; Magnetic nanoparticle heating; Thermal therapy

Indexed keywords

APPLIED FIELD; CLINICAL APPLICATION; CLINICAL USE; INDUCTIVE COUPLINGS; MAGNETIC FLUID HYPERTHERMIA; MAGNETIC NANOPARTICLES; MICROLITERS; PHYSICAL LIMITS; SCALING ANALYSIS; SUPERPARAMAGNETICS; THERMAL THERAPIES; TUMOR VOLUMES;

ELECTROMAGNETIC INDUCTION; FERROMAGNETIC MATERIALS; FERROMAGNETISM; HEAT TRANSFER; HYPERTHERMIA THERAPY; MAGNETIC FLUIDS; NANOPARTICLES; SUPERPARAMAGNETISM; TUMORS;

HEATING;

MAGNETITE NANOPARTICLE;

ARTICLE; HEAT; HYPERTHERMIC THERAPY; MAGNETISM; NEOPLASM;

HOT TEMPERATURE; HYPERTHERMIA, INDUCED; MAGNETIC PHENOMENA; MAGNETITE NANOPARTICLES; NEOPLASMS;

EID: 84871627938     PISSN: 00906964     EISSN: 15739686     Source Type: Journal    
DOI: 10.1007/s10439-012-0633-1     Document Type: Article

References (38)

1. Atkinson, W. J., I. A. Brezovich, and D. P. Chakraborty. Usable frequencies in hyperthermia with thermal seeds. In: IEEE Transactions on Biomedical Engineering, 2007, pp. 70-75.
2. Bio-Medical Ferrofluids, Ferrotec Inc. 2012. Available from: http://ferrofluid.ferrotec.com/products/ferrofluid/bioMedical/. Accessed 17 May 2012.
3. Bordelon, D. E., C. Cornejo, C. Grüttner, F. Westphal, T. L. DeWeese, and R. Ivkov. Magnetic nanoparticle heating efficiency reveals magneto-structural differences when characterized with wide ranging and high amplitude alternating magnetic fields. J. Appl. Phys. 109:124904, 2011.
4. Brusentsov, N. A., V. V. Gogosov, T. N. Brusentsova, A. V. Sergeev, N. Y. Jurchenko, A. A. Kuznetsov, O. A. Kuznetsov, and L. I. Shumakov. Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency- induced hyperthermia of MX11 sarcoma cells in vitro. J. Magn. Magn. Mater. 225:113-117, 2001. (Pubitemid 32335283)
5. Carrey, J., B. Mehdaoui, and M. Respaud. Simple models for dynamic hysteresis loop calculations of magnetic single-domain nanoparticles: application to magnetic hyperthermia optimization. J. Appl. Phys. 109:083921, 2011.
6. Chan, D. C. F., D. B. Kirpotin, and P. A. Bunn, Jr. Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer. J. Magn. Magn. Mater. 122:374-378, 1993.
7. Chithrani, B. D., A. A. Ghazani, and W. C. W. Chan. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6:662-668, 2006.
8. Chou, C. K. Use of heating rate and specific absorption rate in the hyperthermia clinic. Int. J. Hyperth. 6:367-370, 1990.
9. Chou, L. Y., K. Ming, and W. C. Chan. Strategies for the intracellular delivery of nanoparticles. Chem. Soc. Rev. 40:233-245, 2010.
10. Creixell, M., A. C. Bohórquez, M. Torres-Lugo, and C. Rinaldi. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano 5:7124-7129, 2011.
11. Etheridge, M., N. Manucherabadi, R. Franklin, and J. Bischof. Superparamagnetic iron oxide nanoparticle heating: a basic tutorial. In: Nanoparticle Heat Transfer and Fluid Flow. CRC Press, 2012, pp. 97-121.
12. Giustini, A. J., R. E. Gottesman, A. A. Petryk, A. M. Rauwerdink, and P. J. Hoopes. Kinetics and pathogenesis of intracellular magnetic nanoparticle cytotoxicity. Proc. SPIE 7901:790118-790118-7, 2011.
13. Giustini, A. J., R. Ivkov, and P. J. Hoopes. An in vivo transmission electron microscopy study of injected dextran-coated iron-oxide nanoparticle location in murine breast adenocarcinoma tumors versus time. Proc. SPIE 7181:71810M-71810M-8, 2009.
14. Gneveckow, U., A. Jordan, R. Scholz, V. Brüss, N. Waldöfner, J. Ricke, A. Feussner, B. Hildebrandt, B. Rau, and P. Wust. Description and characterization of the novel hyperthermia-and thermoablation-system MFH300F for clinical magnetic fluid hyperthermia. Med. Phys. 31:1444, 2004. (Pubitemid 38808512)
15. Goldenberg, H., and C. J. Tranter. Heat flow in an infinite medium heated by a sphere. Br. J. Appl. Phys. 3:296-298, 1952.
16. Hergt, R., W. Andra, C. G. d'Ambly, I. Hilger, W. A. Kaiser, U. Richter, and H. G. Schmidt. Physical limits of hyperthermia using magnetite fine particles. IEEE Trans. Magn. 34:3745-3754, 1998.
17. Hergt, R., S. Dutz, R. Müller, and M. Zeisberger. Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J. Phys. Condens. Matter 18:S2919, 2006. (Pubitemid 44523010)
18. Hergt, R., S. Dutz, and M. Röder. Effects of size distribution on hysteresis losses of magnetic nanoparticles for hyperthermia. J. Phys. Condens. Matter 20:385214, 2008.
19. Hoopes, P. J., A. A. Petryk, B. Gimi, A. J. Giustini, J. B. Weaver, J. Bischof, R. Chamberlain, and M. Garwood. In vivo imaging and quantification of iron oxide nanoparticle uptake and biodistribution. Proc. SPIE 8317:83170R-83170R-9, 2012.
20. Jordan, A., P. Wust, H. Fähling, W. John, A. Hinz, and R. Felix. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int. J. Hyperth. 25:499-511, 1993.
21. Jordan, A., P. Wust, R. Scholz, B. Tesche, H. Fähling, T. Mitrovics, T. Vogl, J. Cervos-Navarro, and R. Felix. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int. J. Hyperth. 12:705-722, 1996. (Pubitemid 26402358)
22. Kalambur, V. S., B. Han, B. E. Hammer, T. W. Shield, and J. C. Bischof. In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical applications. Nanotechnology 16:1221, 2005. (Pubitemid 40878628)
23. Kalambur, V. S., E. K. Longmire, and J. C. Bischof. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 23:12329-12336, 2007. (Pubitemid 350197410)
24. Kallumadil, M., M. Tada, T. Nakagawa, M. Abe, P. Southern, and Q. A. Pankhurst. Suitability of commercial colloids for magnetic hyperthermia. J. Magn. Magn. Mater. 321:1509-1513, 2009.
25. Kappiyoor, R., M. Liangruksa, R. Ganguly, and I. K. Puri. The effects of magnetic nanoparticle properties on magnetic fluid hyperthermia. J. Appl. Phys. 108:094702, 2010.
26. Keblinski, P., D. G. Cahill, A. Bodapati, C. R. Sullivan, and T. A. Taton. Limits of localized heating by electromagnetically excited nanoparticles. J. Appl. Phys. 100:054305, 2006. (Pubitemid 44422083)
27. MagForce AG - Overview, MagForce AG 2011. Available from: http://www.magforce.de/en/studien.html. Accessed 17 May 2012.
28. Müller, R., R. Hergt, M. Zeisberger, and W. Gawalek. Preparation of magnetic nanoparticles with large specific loss power for heating applications. J. Magn. Magn. Mater. 289:13-16, 2005. (Pubitemid 40347161)
29. Perrault, S. D., C. Walkey, T. Jennings, H. C. Fischer, and W. C. W. Chan. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9:1909-1915, 2009.
30. Petryk, A. A., R. V. Stigliano, A. J. Giustini, R. E. Gottesman, B. S. Trembly, P. A. Kaufman, and P. J. Hoopes. Comparison of iron oxide nanoparticle and microwave hyperthermia alone or combined with cisplatinum in murine breast tumors. Proc. SPIE 7901:790119-790119-7, 2011.
31. Qin, Z., M. Etheridge, and J. C. Bischof. Nanoparticle heating: nanoscale to bulk effects of electromagnetically heated iron oxide and gold for biomedical applications. Proc. SPIE 7901:79010C-79010C-15, 2011.
32. Rabin, Y. Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? Int. J. Hyperth. 18:194-202, 2002. (Pubitemid 34618578)
33. Rodríguez-Luccioni, H. L., M. Latorre-Esteves, J. Méndez-Vega, O. Soto, A. R. Rodríguez, C. Rinaldi, and M. Torres-Lugo. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int. J. Nanomed. 6:373-380, 2011.
34. Rosensweig, R. E. Heating magnetic fluid with alternating magnetic field. J. Magn. Magn. Mater. 252:370-374, 2002.
35. Urtizberea, A., E. Natividad, A. Arizaga, M. Castro, and A. Mediano. Specific absorption rates and magnetic properties of ferrofluids with interaction effects at low concentrations. J. Phys. Chem. C 114:4916-4922, 2010.
36. Walkey, C. D., and W. C. W. Chan. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem. Soc. Rev. 41:2780-2799, 2011.
37. Wust, P., U. Gneveckow, M. Johannsen, D. Böhmer, T. Henkel, F. Kahmann, J. Sehouli, R. Felix, J. Ricke, and A. Jordan. Magnetic nanoparticles for interstitial thermotherapy - feasibility, tolerance and achieved temperatures. Int. J. Hyperth. 22:673-685, 2006. (Pubitemid 46332053)
38. Wust, P., J. Nadobny, R. Felix, P. Deulhard, A. Louis, and W. John. Strategies for optimized application of annular-phased-array systems in clinical hyperthermia. Int. J. Hyperth. 7:157-173, 1991.